Evaluation of the Impact of a Coordinating Nurse in a Personalized Care Program on Quality of Care, Coordination of the Actors and on Quality of Life for Patients With Lung Cancer

New strategies therapeutics result in a longer survival rate. However their side effects affect the patient's quality of life. Even if these side effects are ambulatory manageable, they require to be treated promptly and tends to increase the active list of patients of the thoracic oncology.

Due to the alteration in the care provided to lung cancer patient, there is a need to coordinate the available means, inside and outside the hospital, to improve the quality of care and the quality of life of the patient.

Every patient of the thoracic oncology department receives a personalized care program as a routine practice. In this study, a coordinating nurse (CN) will be added to the personalized care program. Patients newly diagnosed with a lung cancer will be randomized either in the group with a CN or in the group without a CN.

The study will last one year maximum for each participant. Their quality of life, their satisfaction of the quality of the personalized care program - and their general practitioner's satisfaction - will be evaluated throughout the study.

Inclusion criteria

• Patient of the thoracic oncology ward between April and November 2016
• Newly diagnosed lung cancer
• Treated in the pneumology ward of the Mulhouse Hospital (France)
• Patient enrolled in another clinical trial can also be enrolled in this study
• Patients who have not disagreed to participate to the study

Exclusion criteria

• Secondary cancer in lung
• Relapse of primary cancer in lung of the same histological type
• Previous enrollment in this study
• Uncontrolled psychological problem